Perspective Therapeutics Announces Publication of Four Preclinical Studies in Peer-Reviewed Journals

SEATTLE, Nov. 27, 2023 -- Perspective, Therapeutics, Inc. , today announced the publication of four preclinical studies in support of the Company’s discovery pipeline. The studies...

Related Keywords

United States ,Columbus ,Ohio ,Seoul ,Soult Ukpyolsi ,South Korea ,Iowa City ,Iowa ,Germany ,Alabama ,University Of Alabama At Birmingham ,Coralville ,University Of Iowa ,Ohio State University ,Korea ,Republic Of Korea ,Michael Schultz ,Perspective Therapeutics Inc ,Journal Of Nuclear Medicine ,European Journal Of Nuclear Medicine ,Ohio State University College Of Veterinary Medicine ,Exchange Commission ,Therapeutics Inc ,Korea Military Academy ,University Of Alberta Nelson ,Nuclear Medicine ,Department Of Energy ,Technical University Dresden ,University Hospital Carl Gustav Carus ,European Journal ,Molecular Imaging ,Chief Science Officer ,Molar Activity ,Somatostatin Receptor Type ,Structural Modifications Toward Improved ,Perspective Therapeutics ,Optimized Methods ,Using Electroplated Thallium ,Pre Clinical Evaluation ,Early Detection ,Nationwide Children ,Ohio State University College ,Veterinary Medicine ,Transition Report ,Quarterly Report ,Markets ,